Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports.Check Now!

SALE

Panic Disorder - Market Insight, Epidemiology And Market Forecast - 2032

Published Date : 2023

Pages : 200

Region : United States, Japan, EU4 & UK

SALE

Summary
TOC Table of Content
LOT
Companies
- Sample Request

Panic Disorder Market

DelveInsight's "Panic Disorder Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Panic Disorder, historical and forecasted epidemiology as well as the Panic Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Panic Disorder market report provides current treatment practices, emerging drugs, Panic Disorder market share of the individual therapies, current and forecasted Panic Disorder market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Panic Disorder treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Panic Disorder market.

Geography Covered

The United States
EU5 (Germany, France, Italy, Spain, and the United Kingdom)
Japan

Study Period: 2019-2032

Panic Disorder Disease Understanding and Treatment Algorithm

The DelveInsight’s Panic Disorder market report gives a thorough understanding of the Panic Disorder by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis, and treatment.

Panic Disorder Diagnosis

This segment of the report covers the detailed diagnostic methods or tests for Panic Disorder.

Panic Disorder Treatment

It covers the details of conventional and current medical therapies available in the Panic Disorder market for the treatment of the condition. It also provides Panic Disorder treatment algorithms and guidelines in the United States, Europe, and Japan.

Panic Disorder Epidemiology

The Panic Disorder epidemiology section provides insights about the historical and current Panic Disorder patient pool and forecasted trends for individual seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Panic Disorder market report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Panic Disorder epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.

Country Wise- Panic Disorder Epidemiology

The epidemiology segment also provides the Panic Disorder epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Panic Disorder Drug Chapters

The drug chapter segment of the Panic Disorder report encloses the detailed analysis of Panic Disorder marketed drugs and late-stage (Phase-III and Phase-II) Panic Disorder pipeline drugs. It also helps to understand the Panic Disorder clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Panic Disorder Marketed Drugs

The report provides the details of the marketed products/off-label treatments available for Panic Disorder treatment.

Panic Disorder Emerging Drugs

The report provides the details of the emerging therapies under the late and mid-stage of development for Panic Disorder treatment.

Panic Disorder Market Outlook

The Panic Disorder market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Panic Disorder market trends by analyzing the impact of current Panic Disorder therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of Panic Disorder market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Panic Disorder market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Panic Disorder market in 7MM is expected to witness a major change in the study period 2019-2032.

Key Findings

This section includes a glimpse of the Panic Disorder market in 7MM.

The United States Market Outlook

This section provides the total Panic Disorder market size and market size by therapies in the United States.

EU-5 Countries: Market Outlook

The total Panic Disorder market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.

Japan Market Outlook

The total Panic Disorder market size and market size by therapies in Japan is also mentioned.

Panic Disorder Drugs Uptake

This section focuses on the rate of uptake of the potential Panic Disorder drugs recently launched in the Panic Disorder market or expected to get launched in the market during the study period 2019-2032. The analysis covers Panic Disorder market uptake by drugs; patient uptake by therapies; and sales of each drug.

Panic Disorder Drugs Uptake helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs, and allow the comparison of the drugs on the basis of Panic Disorder market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Panic Disorder Pipeline Development Activities

The Panic Disorder report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Panic Disorder key players involved in developing targeted therapeutics.

Pipeline Development Activities

The Panic Disorder report covers the detailed information of collaborations, acquisition, and merger, licensing, patent details, and other information for Panic Disorder emerging therapies.

Reimbursement Scenario in Panic Disorder

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

KOL- Views

To keep up with current Panic Disorder market trends, we take KOLs and SMEs ' opinion working in the Panic Disorder domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Panic Disorder market trends. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Competitive Intelligence Analysis

We perform Competitive and Market Intelligence analysis of the Panic Disorder Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.

Scope of the Report

The report covers the descriptive overview of Panic Disorder, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
Comprehensive insight has been provided into the Panic Disorder epidemiology and treatment in the 7MM
Additionally, an all-inclusive account of both the current and emerging therapies for Panic Disorder is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
A detailed review of the Panic Disorder market; historical and forecasted is included in the report, covering drug outreach in the 7MM
The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Panic Disorder market

Report Highlights

In the coming years, the Panic Disorder market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
The companies and academics are working to assess challenges and seek opportunities that could influence Panic Disorder R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
Major players are involved in developing therapies for Panic Disorder. The launch of emerging therapies will significantly impact the Panic Disorder market
A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Panic Disorder
Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Panic Disorder Report Insights

Panic Disorder Patient Population
Therapeutic Approaches
Panic Disorder Pipeline Analysis
Panic Disorder Market Size and Trends
Panic Disorder Market Opportunities
Impact of upcoming Panic Disorder Therapies

Panic Disorder Report Key Strengths

11 Years Forecast
7MM Coverage
Panic Disorder Epidemiology Segmentation
Key Cross Competition
Highly Analyzed Market
Drugs Uptake

Panic Disorder Report Assessment

Current Treatment Practices
Unmet Needs
Panic Disorder Pipeline Product Profiles
Panic Disorder Market Attractiveness
Market Drivers and Barriers

Key Questions

Market Insights:

What was the Panic Disorder drug class share (%) distribution in 2019 and how it would look like in 2032?
What would be the Panic Disorder total market size as well as market size by therapies across the 7MM during the forecast period (2019-2032)?
What are the key findings pertaining to the market across 7MM and which country will have the largest Panic Disorder market size during the forecast period (2019-2032)?
At what CAGR, the Panic Disorder market is expected to grow by 7MM during the forecast period (2019-2032)?
What would be the Panic Disorder market outlook across the 7MM during the forecast period (2019-2032)?
What would be the Panic Disorder market growth till 2032, and what will be the resultant market Size in the year 2032?
How would the unmet needs affect the market dynamics and subsequent analysis of the associated trends?

Epidemiology Insights:

What are the disease risk, burden, and regional/ethnic differences of the Panic Disorder?
What are the key factors driving the epidemiology trend for seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
What is the historical Panic Disorder patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
What would be the forecasted patient pool of Panic Disorder in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
Where will be the growth opportunities in the 7MM with respect to the patient population pertaining to Panic Disorder?
Out of all 7MM countries, which country would have the highest prevalent population of Panic Disorder during the forecast period (2019-2032)?
At what CAGR the patient population is expected to grow in 7MM during the forecast period (2019-2032)?

Current Treatment Scenario, Marketed Drugs and Emerging Therapies:

What are the current options for the Panic Disorder treatment in addition to the approved therapies?
What are the current treatment guidelines for the treatment of Panic Disorder in the USA, Europe, and Japan?
What are the Panic Disorder marketed drugs and their respective MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
How many companies are developing therapies for the treatment of Panic Disorder?
How many therapies are in-development by each company for Panic Disorder treatment?
How many are emerging therapies in mid-stage, and late stage of development for Panic Disorder treatment?
What are the key collaborations (Industry - Industry, Industry - Academia), Mergers and acquisitions, licensing activities related to the Panic Disorder therapies?
What are the recent novel therapies, targets, mechanisms of action and technologies being developed to overcome the limitation of existing therapies?
What are the clinical studies going on for Panic Disorder and their status?
What are the current challenges faced in drug development?
What are the key designations that have been granted for the emerging therapies for Panic Disorder?
What are the global historical and forecasted market of Panic Disorder?

Reasons to buy

The report will help in developing business strategies by understanding trends shaping and driving the Panic Disorder market
To understand the future market competition in the Panic Disorder market and Insightful review of the key market drivers and barriers
Organize sales and marketing efforts by identifying the best opportunities for Panic Disorder in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
Organize sales and marketing efforts by identifying the best opportunities for Panic Disorder market
To understand the future market competition in the Panic Disorder market

1. Key Insights

2. Executive Summary of Panic Disorder

3. Competitive Intelligence Analysis for Panic Disorder

4. Panic Disorder: Market Overview at a Glance

4.1. Panic Disorder Total Market Share (%) Distribution in 2019

4.2. Panic Disorder Total Market Share (%) Distribution in 2032

5. Panic Disorder: Disease Background and Overview

5.1. Introduction

5.2. Sign and Symptoms

5.3. Pathophysiology

5.4. Risk Factors

5.5. Diagnosis

6. Patient Journey

7. Panic Disorder Epidemiology and Patient Population

7.1. Epidemiology Key Findings

7.2. Assumptions and Rationale: 7MM

7.3. Epidemiology Scenario: 7MM

7.3.1. Panic Disorder Epidemiology Scenario in the 7MM (2019-2032)

7.4. United States Epidemiology

7.4.1. Panic Disorder Epidemiology Scenario in the United States (2019-2032)

7.5. EU-5 Country-wise Epidemiology

7.5.1. Germany Epidemiology

7.5.1.1. Panic Disorder Epidemiology Scenario in Germany (2019-2032)

7.5.2. France Epidemiology

7.5.2.1. Panic Disorder Epidemiology Scenario in France (2019-2032)

7.5.3. Italy Epidemiology

7.5.3.1. Panic Disorder Epidemiology Scenario in Italy (2019-2032)

7.5.4. Spain Epidemiology

7.5.4.1. Panic Disorder Epidemiology Scenario in Spain (2019-2032)

7.5.5. United Kingdom Epidemiology

7.5.5.1. Panic Disorder Epidemiology Scenario in the United Kingdom (2019-2032)

7.5.6. Japan Epidemiology

7.5.6.1. Panic Disorder Epidemiology Scenario in Japan (2019-2032)

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Panic Disorder Treatment and Management

8.2. Panic Disorder Treatment Algorithm

9. Panic Disorder Unmet Needs

10. Key Endpoints of Panic Disorder Treatment

11. Panic Disorder Marketed Products

11.1. List of Panic Disorder Marketed Drugs in the 7MM

11.2. Drug Name: Company Name

11.2.1. Product Description

11.2.2. Regulatory Milestones

11.2.3. Other Developmental Activities

11.2.4. Pivotal Clinical Trials

11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Panic Disorder Emerging Therapies

12.1. Key Cross

12.2. Drug Name: Company Name

12.2.1. Product Description

12.2.2. Other Developmental Activities

12.2.3. Clinical Development

12.2.4. Safety and Efficacy

12.2.5. Product Profile

List to be continued in report

13. Panic Disorder: Seven Major Market Analysis

13.1. Key Findings

13.2. Panic Disorder Market Size in 7MM

13.3. Panic Disorder Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

15.1. United States: Market Size

15.1.1. Panic Disorder Total Market Size in the United States

15.1.2. Panic Disorder Market Size by Therapies in the United States

15.2. EU-5 countries: Market Size and Outlook

15.3. Germany Market Size

15.3.1. Panic Disorder Total Market Size in Germany

15.3.2. Panic Disorder Market Size by Therapies in Germany

15.4. France Market Size

15.4.1. Panic Disorder Total Market Size in France

15.4.2. Panic Disorder Market Size by Therapies in France

15.5. Italy Market Size

15.5.1. Panic Disorder Total Market Size in Italy

15.5.2. Panic Disorder Market Size by Therapies in Italy

15.6. Spain Market Size

15.6.1. Panic Disorder Total Market Size in Spain

15.6.2. Panic Disorder Market Size by Therapies in Spain

15.7. United Kingdom Market Size

15.7.1. Panic Disorder Total Market Size in the United Kingdom

15.7.2. Panic Disorder Market Size by Therapies in the United Kingdom

15.8. Japan Market Outlook

15.8.1. Japan Market Size

15.8.2. Panic Disorder Total Market Size in Japan

15.8.3. Panic Disorder Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Panic Disorder

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

*The table of contents is not exhaustive; the final content may vary.

List of Tables:

List of Table

Table 1: 7MM Panic Disorder Epidemiology (2019-2032)

Table 2: 7MM Panic Disorder Diagnosed and Treatable Cases (2019-2032)

Table 3: Panic Disorder Epidemiology in the United States (2019-2032)

Table 4: Panic Disorder Diagnosed and Treatable Cases in the United States (2019-2032)

Table 5: Panic Disorder Epidemiology in Germany (2019-2032)

Table 6: Panic Disorder Diagnosed and Treatable Cases in Germany (2019-2032)

Table 7: Panic Disorder Epidemiology in France (2019-2032)

Table 8: Panic Disorder Diagnosed and Treatable Cases in France (2019-2032)

Table 9: Panic Disorder Epidemiology in Italy (2019-2032)

Table 10: Panic Disorder Diagnosed and Treatable Cases in Italy (2019-2032)

Table 11: Panic Disorder Epidemiology in Spain (2019-2032)

Table 12: Panic Disorder Diagnosed and Treatable Cases in Spain (2019-2032)

Table 13: Panic Disorder Epidemiology in the UK (2019-2032)

Table 14: Panic Disorder Diagnosed and Treatable Cases in the UK (2019-2032)

Table 15: Panic Disorder Epidemiology in Japan (2019-2032)

Table 16: Panic Disorder Diagnosed and Treatable Cases in Japan (2019-2032)

Table 17: Drug Name, Clinical Trials by Recruitment status

Table 18: Drug Name, Clinical Trials by Zone

Table 19: Total Seven Major Market Size in USD, Million (2019-2032)

Table 20: Region-wise Market Size in USD, Million (2019-2032)

Table 21: 7MM-Market Size by Therapy in USD, Million (2019-2032)

Table 22: United States Market Size in USD, Million (2019-2032)

Table 23: United States Market Size by Therapy in USD, Million (2019-2032)

Table 24: Germany Market Size in USD, Million (2019-2032)

Table 25: Germany Market Size by Therapy in USD, Million (2019-2032)

Table 26: France Market Size in USD, Million (2019-2032)

Table 27: France Market Size by Therapy in USD, Million (2019-2032)

Table 28: Italy Market Size in USD, Million (2019-2032)

Table 29: Italy Market Size by Therapy in USD, Million (2019-2032)

Table 30: Spain Market Size in USD, Million (2019-2032)

Table 31: Spain Market Size by Therapy in USD, Million (2019-2032)

Table 32: United Kingdom Market Size in USD, Million (2019-2032)

Table 33: United Kingdom Market Size by Therapy in USD, Million (2019-2032)

Table 34: Japan Market Size in USD, Million (2019-2032)

Table 35: Japan Market Size by Therapy in USD, Million (2019-2032)

*The list of tables is not exhaustive; the final content may vary

List of Figures:

List of Figures

Figure 1: 7MM Panic Disorder Epidemiology (2019-2032)

Figure 2: 7MM Panic Disorder Diagnosed and Treatable Cases (2019-2032)

Figure 3: Panic Disorder Epidemiology in the United States (2019-2032)

Figure 4: Panic Disorder Diagnosed and Treatable Cases in the United States (2019-2032)

Figure 5: Panic Disorder Epidemiology in Germany (2019-2032)

Figure 6: Panic Disorder Diagnosed and Treatable Cases in Germany (2019-2032)

Figure 7: Panic Disorder Epidemiology in France (2019-2032)

Figure 8: Panic Disorder Diagnosed and Treatable Cases in France (2019-2032)

Figure 9: Panic Disorder Epidemiology in Italy (2019-2032)

Figure 10: Panic Disorder Diagnosed and Treatable Cases in Italy (2019-2032)

Figure 11: Panic Disorder Epidemiology in Spain (2019-2032)

Figure 12: Panic Disorder Diagnosed and Treatable Cases in Spain (2019-2032)

Figure 13: Panic Disorder Epidemiology in the UK (2019-2032)

Figure 14: Panic Disorder Diagnosed and Treatable Cases in the UK (2019-2032)

Figure 15: Panic Disorder Epidemiology in Japan (2019-2032)

Figure 16: Panic Disorder Diagnosed and Treatable Cases in Japan (2019-2032)

Figure 17: Drug Name, Clinical Trials by Recruitment status

Figure 18: Drug Name, Clinical Trials by Zone

Figure 19: Total Seven Major Market Size in USD, Million (2019-2032)

Figure 20: Region-wise Market Size in USD, Million (2019-2032)

Figure 21: 7MM-Market Size by Therapy in USD, Million (2019-2032)

Figure 22: United States Market Size in USD, Million (2019-2032)

Figure 23: United States Market Size by Therapy in USD, Million (2019-2032)

Figure 24: Germany Market Size in USD, Million (2019-2032)

Figure 25: Germany Market Size by Therapy in USD, Million (2019-2032)

Figure 26: France Market Size in USD, Million (2019-2032)

Figure 27: France Market Size by Therapy in USD, Million (2019-2032)

Figure 28: Italy Market Size in USD, Million (2019-2032)

Figure 29: Italy Market Size by Therapy in USD, Million (2019-2032)

Figure 30: Spain Market Size in USD, Million (2019-2032)

Figure 31: Spain Market Size by Therapy in USD, Million (2019-2032)

Figure 32: United Kingdom Market Size in USD, Million (2019-2032)

Figure 33: United Kingdom Market Size by Therapy in USD, Million (2019-2032)

Figure 34: Japan Market Size in USD, Million (2019-2032)

Figure 35: Japan Market Size by Therapy in USD, Million (2019-2032)

*The list of figures is not exhaustive; the final content may vary

Frequently Asked Questions

What is Panic Disorder?

Panic Disorder is an anxiety disorder where you regularly have sudden attacks of panic or fear. People with Panic Disorder have sudden and repeated attacks of fear that last for several minutes or longer. These are called panic attacks. Panic attacks are characterized by a fear of disaster or of losing control even when there is no real danger. A person may also have a strong physical reaction during a panic attack. It may feel like having a heart attack. Panic attacks can occur at any time, and many people with Panic Disorder worry about and dread the possibility of having another attack. A person with Panic Disorder may become discouraged and feel ashamed because he or she cannot carry out normal routines like going to school or work, going to the grocery store, or driving. Panic Disorder often begins in the late teens or early adulthood. More women than men have Panic Disorder. But not everyone who experiences panic attacks will develop Panic Disorder.

How is Panic Disorder epidemiology segmented?

Panic Disorder epidemiology is segmented as Panic Disorder Total Incident Cases, Age-specific Panic Disorder cases, Gender-specific Panic Disorder Cases, Stage-specific Panic Disorder incident cases, Type-specific Panic Disorder incident cases, and Total Treated Panic Disorder Cases.

What is the Panic Disorder market size in 7MM?

The Panic Disorder market size is expected to grow owing to the launch of emerging therapies by 2032.

At what CAGR is the Panic Disorder Market expected to grow by 2032?

The Panic Disorder Market is expected to grow at a moderate CAGR during the study period 2019–2032.

Which country is expected to account for the most significant Panic Disorder prevalent cases in the 7MM?

The United States is expected to account for the highest prevalent Panic Disorder prevalent cases.

What are the key Panic Disorder companies?

Some of the key Panic Disorder companies working in the Panic Disorder market are Cerevel Therapeutics, Janssen Research & Development, Addex Pharmaceuticals, Neurelis, VistaGen Therapeutics, and others.

Tags:

License Type

Offer

Panic Disorder Market

Get a Sneak Peek at the Latest panic disorder market Report

Request Sample

View Pricing

Customize Reports As Per Your Needs

Don't see what you're looking for? Get a report tailored to your specific requirements. Customize your report now!

Have a Question?

We are happy to assist you.

+91-9650213330

info@delveinsight.com

DelveInsight
SUBSCRIPTION
Platform

Panic Disorder Market

Geography Covered

Panic Disorder Disease Understanding and Treatment Algorithm

Panic Disorder Epidemiology

Panic Disorder Drug Chapters

Panic Disorder Market Outlook

Panic Disorder Drugs Uptake

Reimbursement Scenario in Panic Disorder

KOL- Views

Competitive Intelligence Analysis

Scope of the Report

Report Highlights

Panic Disorder Report Insights

Panic Disorder Report Key Strengths

Panic Disorder Report Assessment

Key Questions

Current Treatment Scenario, Marketed Drugs and Emerging Therapies:

Reasons to buy

Frequently Asked Questions

What is Panic Disorder?

How is Panic Disorder epidemiology segmented?

What is the Panic Disorder market size in 7MM?

At what CAGR is the Panic Disorder Market expected to grow by 2032?

Which country is expected to account for the most significant Panic Disorder prevalent cases in the 7MM?

What are the key Panic Disorder companies?

Tags:

Panic Disorder Market

Customize Reports As Per Your Needs

Have a Question?

Latest Press Release